Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jun;48(6):634-9.
doi: 10.1038/ng.3561. Epub 2016 May 2.

Variants with large effects on blood lipids and the role of cholesterol and triglycerides in coronary disease

Affiliations

Variants with large effects on blood lipids and the role of cholesterol and triglycerides in coronary disease

Anna Helgadottir et al. Nat Genet. 2016 Jun.

Abstract

Sequence variants affecting blood lipids and coronary artery disease (CAD) may enhance understanding of the atherogenicity of lipid fractions. Using a large resource of whole-genome sequence data, we examined rare and low-frequency variants for association with non-HDL cholesterol, HDL cholesterol, LDL cholesterol, and triglycerides in up to 119,146 Icelanders. We discovered 13 variants with large effects (within ANGPTL3, APOB, ABCA1, NR1H3, APOA1, LIPC, CETP, LDLR, and APOC1) and replicated 14 variants. Five variants within PCSK9, APOA1, ANGPTL4, and LDLR associate with CAD (33,090 cases and 236,254 controls). We used genetic risk scores for the lipid fractions to examine their causal relationship with CAD. The non-HDL cholesterol genetic risk score associates most strongly with CAD (P = 2.7 × 10(-28)), and no other genetic risk score associates with CAD after accounting for non-HDL cholesterol. The genetic risk score for non-HDL cholesterol confers CAD risk beyond that of LDL cholesterol (P = 5.5 × 10(-8)), suggesting that targeting atherogenic remnant cholesterol may reduce cardiovascular risk.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Relationship between the effect of sequence variants on non-HDL cholesterol and their effect on risk of coronary artery disease, (a) Effect on CAD risk of 100 known common (minor allele frequency (MAF) >5%) lipid-associated variants,, that associate with non-HDL cholesterol in Iceland (P < 0.05). (b) Effect on CAD of the 27 rare and low-frequency lipid-associated variants identified in this study. Previously published variants are colored blue, and new variants are colored red. In both plots, the effect on non-HDL cholesterol (n = 119,146) is given in mmol/L, and the effect on CAD risk (n = 33,090 cases and 236,254 controls) is represented by the odds ratio (OR). Bars represent 95% confidence intervals for the effect on non-HDL cholesterol and risk of CAD. The black line is the line best fitting the common variant, and the gray line is the line best fitting the CAD odds ratio on the log scale transformed back to the original scale.

References

    1. Barter PJ et al. Effects of torcetrapib in patients at high risk for coronary events. N. Engl. J. Med 357, 2109–2122 (2007). - PubMed
    1. Schwartz GG et al. Effects of dalcetrapib in patients with a recent acute coronary syndrome. N. Engl. J. Med 367, 2089–2099 (2012). - PubMed
    1. HPS2-THRIVE Collaborative Group. Effects of extended-release niacin with laropiprant in high-risk patients. N. Engl. J. Med 371, 203–212 (2014). - PubMed
    1. Peloso GM et al. Association of low-frequency and rare coding-sequence variants with blood lipids and coronary heart disease in 56,000 whites and blacks. Am. J. Hum. Genet 94, 223–232 (2014). - PMC - PubMed
    1. Lange LA et al. Whole-exome sequencing identifies rare and low-frequency coding variants associated with LDL cholesterol. Am. J. Hum. Genet 94, 233–245 (2014). - PMC - PubMed

Publication types